AbbVie Inc. (ABBV)
3 High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade
If you're worried about having enough passive income to maintain your lifestyle during retirement, you're not alone. Having to spend more just to maintain their current standard of living is a constant concern for most families.
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
The Zacks Analyst Blog Eli Lilly, J&J, AbbVie, AstraZeneca and Pfizer
Eli Lilly, J&J, AbbVie, AstraZeneca and Pfizer are included in this Analyst Blog.
AbbVie (ABBV) Upgraded to Buy: What Does It Mean for the Stock?
AbbVie (ABBV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Brokers Suggest Investing in AbbVie (ABBV): Read This Before Placing a Bet
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It
Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.
Highest Quality Dividend Kings For 2025
Only 11 Dividend Kings outperformed the S&P 500 during the last decade based on Total Return. 5 Dividend Kings earn the rank of "High Quality" based on my custom quantitative model. Using a variation of a truncated custom quality score could have generated a total return nearly double that of the S&P 500 during the last 9 years.
The Smartest Dividend Stocks to Buy With $1,000 Right Now
If you're looking for attractive dividend-paying stocks, that's a smart move. If you're not, perhaps reconsider -- because:
AbbVie (ABBV) Rises Yet Lags Behind Market: Some Facts Worth Knowing
In the latest trading session, AbbVie (ABBV) closed at $180, marking a +0.9% move from the previous day.
Into 2025: Top 8 Stocks I Own And Why (Part II)
2024 is going out with a bang as mystery drones, Federal Reserve hawkishness, and quantum stocks dominate headlines. It's time to look towards 2025 after another banner year for stocks. Here are four stocks in timely, tremendous industries to keep on your radar.
Is AbbVie Stock a Buy?
With its shares offering a total return of nearly 49% over the last three years, trumping the market's return of 33%, AbbVie (ABBV 2.37%) is a powerhouse big pharma that has a lot of upside to offer to investors.
2 Excellent Dividend Stocks to Buy on the Dip
AbbVie (ABBV 2.37%) and Amgen (AMGN 0.84%) have a lot in common. They are both leading drugmakers and have strong dividend track records.
